WallStreetZenWallStreetZen

NASDAQ: ALZN
Alzamend Neuro Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ALZN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.4M
Current Profit Margin
0%

ALZN Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when ALZN announces earnings.

ALZN Return on Assets

Current Company
-481.2%
Current Industry
2.9%
ALZN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALZN Return on Capital Employed

Current Company
407.14%
Current Industry
19.5%
ALZN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALZN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALZN$0.00-$12.35M-$12.40MN/AN/A
LGVN$709.00k-$20.47M-$22.21M-19.78%N/A
SNPX$0.00-$6.03M-$13.78MN/AN/A
XCUR$23.79M$5.04M$3.07M+38.63%-72.96%
OGEN$37.65k-$20.60M-$20.66M-34.21%N/A
View Top Biotech Stocks

Alzamend Neuro Earnings & Revenue FAQ

What were ALZN's earnings last quarter?

On Invalid Date, Alzamend Neuro (NASDAQ: ALZN) reported Q4 2023 earnings per share (EPS) of -$0.38, up 54.22% year over year. Total Alzamend Neuro earnings for the quarter were -$2.66 million. In the same quarter last year, Alzamend Neuro's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.

What was ALZN's earnings growth in the past year?

As of Q2 2024, Alzamend Neuro's earnings has grown year over year. Alzamend Neuro's earnings in the past year totalled -$12.40 million.

What was ALZN's revenue last quarter?

On Invalid Date, Alzamend Neuro (NASDAQ: ALZN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Alzamend Neuro's revenue was $0.00.

What was ALZN's revenue growth in the past year?

As of Q2 2024, Alzamend Neuro's revenue has grown null year over year. Alzamend Neuro's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.